Protection against Fasciola gigantica using paramyosin antigen as a candidate for vaccine production

Pakistan Journal of Biological Sciences

Volumn 16, Issue 22, 2013, Pages 1449-1458

  Abou Elhakam, H ^a   Rabee, I ^b   El Deeb, S ^a   El Amir, A ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

Author keywords

Cytokines; F. gigantica; IGs isotypes; Pmy; Vaccine

Indexed keywords

CYTOKINE; HELMINTH ANTIBODY; PARASITE ANTIGEN; PROTOZOAL VACCINE; TROPOMYOSIN;

ANIMAL; ARTICLE; BLOOD; CELLULAR IMMUNITY; CLASSIFICATION; DISEASE MODEL; FASCIOLA; FASCIOLIASIS; GROWTH, DEVELOPMENT AND AGING; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PARASITOLOGY; RABBIT; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CYTOKINES; DISEASE MODELS, ANIMAL; FASCIOLA; FASCIOLIASIS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNIZATION; INJECTIONS, INTRAMUSCULAR; MALE; PROTOZOAN VACCINES; RABBITS; TH1 CELLS; TH2 CELLS; TROPOMYOSIN;

EID: 84877356570     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2013.1449.1458     Document Type: Article

References (52)

1. Awad, W.S., A.K. Ibrahim and F.A. Salib, 2009. Using indirect ELISA to assess different antigens for the serodiagnosis of Fasciola gigantic infection in cattle, sheep and donkeys. Res. Vet. Sci., 86: 466-471.
2. Barduagni, P., Y. Hassanein, M. Mohamed, A.E. Wakeel, M.E. Sayed, Z. Hallaj and F. Curtale, 2008. Use of triclabendazole for treatment of patients co-infected by Fasciola spp. and Schistosoma mansoni in Behera Governorate, Egypt. Paras itol. Res., 102: 631-633.
3. Bossaert, K., F. Farnir, T. Leclipteux, M. Protz, J.F. Lonneux and B. Losson, 2000. Humoral immune-response in calves to single-dose, trickle and challenge infections with Fasciola hepatica. Vet. Parasitol, 87: 103-123.
4. Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254.
5. Campbell, R.C., 1989. Statistics for Biologists. 3rdEdn, Cambridge University Press, Cambridge, UK., Pages: 446.
6. Cancela, M., C. Carmona, S. Rossi, B. Frangione, F. Goni and P. Berasain, 2004. Purification, characterization and immunolocahzation of paramyosin from the adult stage of Fasciola hepatica. Parasitol. Res., 92: 441-448.
7. Chen, H., T. Nara, X. Zeng, M. Satoh and G. Wu et at., 2000. Vaccination of domestic pig with recombinant paramyosin: Against Schistosoma japonicum in China. Vaccine, 18: 2142-2146.
8. Dalton, J.P., S.O. Neill, C. Stack, P. Collins and A. Walshe et at, 2003. Fasciola hepatica cathepsin L-like proteases: biology, function and potential in the development of first generation liver fluke vaccines. Int. J. Parasitol, 33: 1173-1181.
9. De Jesus, A.R., I. Araujo, O.V. Bacellar, A. Magalhaes and E. Pearce et al., 2000. Human immune responses to Schistosoma mansoni vaccine candidate antigens. Infect. Immunity, 68: 2797-2803.
10. Dixit, A.K., P. Dixit and R.L. Sharma, 2008. Immunodiagnostic/protective role of cathepsin L cysteine proteinases secreted by Fasciola species. Vet. Parasitol., 154: 177-184.
11. Engvall, E. and P. Perlmann, 1971. Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin G. Immunochemistry, 8: 871-874.
12. Farahnak, A., T. Golmohamadi and M.B.M. Rad, 2010. Carbohydrate detection and lectin isolation from tegumental tissue of Fasciola hepatica. Iran. J. Parasitol, 5: 20-24.
13. Fonseca, C.T., C.F. Bnto, J.B. Alves and S.C. Oliveira, 2004. IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN- Y and TNF- B dependent pathway. Vaccine, 22: 503-510.
14. Garcia, L.S., 2001. Liver and Lung Trematodes. In: Diagnostic Medical Parasitology. Garcia, L.S. (Ed.). 4th Edn., ASM Press, Washington, DC, USA., ISBN: 9781555812003 pp: 433-436.
15. Garcia, T.C., C.T. Fonseca, L.G. Pacifico, V. Duraes Fdo and F.A. Marinho et al, 2008. Peptides containing T cell epitopes, derived from Sm 14, but not from paramyosin, induce a Thl type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice. Acta Trop., 106: 162-167.
16. Girones, N, M.A. Valero, M.A. Garcia-Bodelon, I. Chico-Calero, C. Punzon, M. Fresno and S. Mas-Coma, 2007. Immune suppression in advanced chronic fascioliasis: an experimental study maratmodel. J. Infect. Dis., 195: 1504-1512.
17. Gobert, G.N. and D.P. McManus, 2005. Update on paramyosin in parasitic worms. Parasitol. Int., 54: 101-107.
18. Hansen, D., D. Clery, S. Estuningsih, S. Widjajanti, S. Partoutomo and T. Spithill, 1999. Immune responses in Indonesian thin tail and Merino sheep during a primary infection with Fasciola gigantica: Lack of a specific IgG2 antibody response is associated with increased resistance to infection in Indonesian sheep. Int. J. Parasitol., 29: 1027-1035.
19. Intapan, P.M., W. Maleewong, S. Nateeworanart, C. Wongkham, V. Pipitgool, V. Sukolapong and S. Sangmaneedet, 2003. Immunodiagnosis of human fascioliasis using an antigen of Fasciola gigantica adult worm with molecular mass of 27 kDa by a dot-ELISA. Southeast Asian J. Trop. Med. Public Health, 34: 713-717.
20. Jayaraj, R., D. Piedrafita, K. Dynon, R. Grams, T.W. Spithill and P.M. Smooker, 2009. Vaccination against fasciolosis by a multivalent vaccine of stage-specific antigens. Vet. Parasitol, 160: 230-236.
21. Jezek, J., R. El-Ridi, M. Salah, A. Wagih and H.W. Aziz et al., 2008. Fasciola gigantica cathepsin L. proteinase-based synthetic peptide for immunodiagnosis and prevention of sheep fasciolosis. Biopolymers, 90: 349-357.
22. Jiz, M., H.W. Wu, R Meng, S. Pond-Tor and M. Reynolds et al, 2008. Pilot-scale production and characterization of paramyosin, a vaccine candidate for Schistosomiasis japonica. Infect. Immunity, 76: 3164-3169.
23. Keiser, J. and J. Utzinger, 2005. Emerging foodborne trematodiasis. Emerging Infect. Dis., 11: 1507-1514.
24. Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227: 680-685.
25. Lopez-Moreno, H.S., D. Correa, J.P. Laclette and V.F. Ortiz-Navarrette, 2003. Identification of CD4+ T cell epitopes of Taenia solium paramyosin. Parasite Immunol, 25: 513-516.
26. Magambo, J.K., E. Zeyhle and T.M. Wachira, 1998. Prevalence of intestinal parasites among children in southern Sudan. East Afr. Med. J., 75: 288-290.
27. Martin, L.K. and P.C. Beaver, 1968. Evaluation of Kato thick smear technique for quantitative diagnosis of helminth infections. Am. J. Trop. Med. Hyg., 17: 382-391.
28. Mas-Coma, S., M.D. Bargues and M.A. Valero, 2005. Fascioliasis and other plant-borne trematode zoonoses. Int. J. Parasitol, 35: 1255-1278.
29. Molina, E.C., 2005. Serum interferon-gamma and interleukins-6 and 8 during infection with Fasciola gigantica in cattle and buffaloes. Vet. Scl, 6: 135-139.
30. Moreau, E., A. Chauvin and C. Boulard, 1998. IFN-gamma and IL-10 production by hepatic lymph node and peripheral blood lymphocytes in Fasciola hepatica infected sheep. Parasite, 5: 307-315.
31. Mulcahy, G., F. O'Connor, S. McGonigle, A. Dowd, D.G. Clery, S.J. Andrews and J.P. Dalton, 1998. Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica. Vaccine, 16: 932-939.
32. Mulcahy, G., P. Joyce and J. Dalton, 1999. Immunology of Fasciola hepatica infection. In: Fasciolosis. Dalton, J.P. (Ed.). CAB International Publishing, Wallingford, UK., ISBN: 9780851992600, pp: 341-375.
33. Muro, A., V. Ramajo, J. Lopez, F. Simon and G. V. Hillyer, 1997. Fasciola hepatica: Vaccination of rabbits with native and recombinant antigens related to fatty acid binding proteins. Vet. Parasitol, 69: 219-229.
34. Nara, T., K. Hzumi, H. Ohmae, O.S. Sy and S. Tsubota et al, 2007. Antibody Isotype Responses to Paramyosin, A Vaccine Candidate for Schistosomiasis and Their Correlations with Resistance and Fibrosis in Patients Infected with Schistosoma japonicum in Leyte, The Philippines. Am. J. Trop. Med. Hyg., 76: 384-391.
35. Nilsson, B.O., 1990. Enzyme-linked immunosorbent assay. Curr. Opin. Immunol, 2: 898-904.
36. ONeill, S.M., M.T. Brady, J.J. Callanan, G. Mulcahy, P. Joyce, K.H.G. Mills and J.P. Dalton, 2000. Fasciola hepatica infection down-regulates Thl responses in mice. Parasite Immunol, 22: 147-155.
37. Oliveira, A.F., L.P. Ruas, S.A. Cardoso, S.G. Soares and M.C. Roque-Barreira, 2010. Vaccination of mice with salmonella expressing VapA: Mucosal and systemic Thl responses provide protection against rhodococcus equi infection. PLoS One, Vol. 5
38. Phiri, A.M., IK. Phiri, C.S. Sikasunge, M. Chembensofu and J. Monrad, 2006. Comparative fluke burden and pathology in condemned and noncondemned cattle livers from selected abattoirs in Zambia. Onderstepoort. Vet. Res., 73: 275-281.
39. Piacenza, L., D. Acosta, I. Basmadjian, J.P. Daltonand, C. Carmona, 1999. Vaccination with cathepsin L proteinases and with leucine aminopeptidase induces high levels of protection against fascioliasis in sheep. InfectImmun., 67: 1954-1961.
40. Piedrafita, D., E. Estuningsih, J. Pleasance, R. Prowse, H.W. Raadsma, E.N.T. Meeusen and T.W. Spithill, 2007. Peritoneal lavage cells of Indonesian thin tail sheep mediate antibody-dependent superoxide radical cytotoxicity in vitro against newly excysted juvenile Fasciola gigantica but not juvenile Fasciola hepatica. Infect. Immunity, 75: 1954-1963.
41. Rama, O.K., D. Snveny and S.C. Yadav, 2004. Humotal immune response against Fasciola gigantica fatty acid binding protein. Vet. Parasitol., 124: 65-72.
42. Ramajo, V., A. Oleaga, P. Casanueva, G.V. Hillyer and A. Muro, 2001. Vaccination of sheep against Fasciola hepatica with homologous fatty acid binding proteins. Vet. Parasitol., 97: 35-46.
43. Sabry, H. and S. Mohamed, 2007. Diagnosis efficacy of anti-cysteine protease for detection of Fasciola antigen in serum and stool samples. New Egy J. Med., 36: 163-169.
44. Sobhon, P., S. Anantavara, T. Dangprasert, V. Viyanant and D. Krailas et al, 1998. Fasciola gigantica: Studies of the tegument as a basis for the developments of immunodiagnosis and vaccine. Southeast Asian J. Trop. Med. Publ. Health, 29: 387-400.
45. Soliman, M.F.M., 2008. Epidemiological review of human and animal fascioliasis in Egypt. J. Infect. Dev. Countries, 2: 182-198.
46. Timanova, A., S. Muller, T. Marti, I. Bankov and R.D. Walter, 1999. Ascaridia galli fatty acid binding protein, a member of the nematode polyprotein allergens family. Eur. J. Biochem., 261: 569-576.
47. Vazquez-Talavera, J., C.F. Solis, L.I. Terrazas and J.P. Laclette, 2001. Characterization and protective potential of the immune response to Taenia solium paramyosin in a murine model of cysticercosis. Infect. Immunity, 69: 5412-5416.
48. Venkatesan, P. and D. Wakelm, 1993. ELISAs for parasitologists: Or lies, damned lies and ELISAs. Parasitol. Today, 9: 228-232.
49. Villa-Mancera, A., H. Quiroz-Romero, D. Correa, F. Ibarra and M. Reyes-Perez et al, 2008. Induction of immunity in sheep to Fasciola hepatica with mimotopes of cathepsin L selected from a phage display library. Parasitology, 135: 1437-1445.
50. World Health Organization, 1995. Control of foodborne trematode infections. WHO Tech. Report Series, 849: 1-157.
51. Zhao, Q.P., S.U. Moon, B.K. Na, S.H. Kim and S.H. Cho et al, 2007. Paragonimus westermani: Biochemical and immunological characterizations of paramyosin. Exp. Parasitol., 115: 9-18.
52. Zhou, S., S. Liu, G. Song, Y. Xu and W. Sun, 2000. Protective immunity induced by the full-length cDNA encoding paramyosin of Chinese Schistosoma japonicum. Vaccine, 18: 3196-3204.